UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000010848 |
|---|---|
| Receipt number | R000012703 |
| Scientific Title | Phase I/II clinical trial of radical radiotherapy using carbon-ion beams for early breast cancer |
| Date of disclosure of the study information | 2013/05/31 |
| Last modified on | 2015/11/30 17:06:58 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Phase I/II clinical trial of radical radiotherapy using carbon-ion beams for early breast cancer
Acronym
Breast I (Protocol 1301)
Scientific Title
Phase I/II clinical trial of radical radiotherapy using carbon-ion beams for early breast cancer
Scientific Title:Acronym
Breast I (Protocol 1301)
Region
| Japan |
Condition
Condition
Breast cancer
Classification by specialty
| Breast surgery | Radiology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To evaluate safety and effectiveness of carbon ion radiotherapy for low risk stage I breast cancer, and to find optimal treatment dose.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Explanatory
Developmental phase
Phase I,II
Assessment
Primary outcomes
1. Acute toxicities of normal tissue
2. Local control
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Maneuver |
Interventions/Control_1
Carbon ion radiotherapy 48 to 60GyE/4fr/4days
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 60 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Female
Key inclusion criteria
1.Pathologically proven invasive ductal carcinoma.
2.Tumor 2 cm or less on MRI.
UICC clinical stage I.
3.Estrogen receptor positive, HER2 negative, No Lymphovascular space invasion, No extensive intraductal component
4.Performance status 0 to 2
5.Age 60 years old and over.
6.No other life-threatening illness
7.Written informed consent
Key exclusion criteria
1.Severe complication
2.Previous treatment
3.Active double primary
4.Tumor invasion to skin or chest wall
5.Distance between tumor border to skin less than 5mm.
6.Previous irradiation at tumor site
7. Non invasive ductal carcinoma
8. Medically, psychologically or other reason who are not suitable for candidate
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Kumiko Karasawa |
Organization
National Institute of Radiological Sciences
Division name
Research Center Hospital for Charged Particle Therapy National Institute of Radiological Sciences
Zip code
Address
4-9-1 Anagawa, Inage-ku, Chiba-city,Chiba 263-8555 JAPAN
TEL
043-206-3306
kkarasaw@nirs.go.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Kumiko Karasawa |
Organization
National Institute of Radiological Sciences
Division name
Research Center Hospital for Charged Particle Therapy National Institute of Radiological Sciences
Zip code
Address
4-9-1 Anagawa, Inage-ku, Chiba-city,Chiba 263-8555 JAPAN
TEL
043-206-3306
Homepage URL
http://www.nirs.go.jp/hospital/index.shtml
kkarasaw@nirs.go.jp
Sponsor or person
Institute
National Institute of Radiological Sciences
Institute
Department
Personal name
Funding Source
Organization
National Institute of Radiological Sciences
Organization
Division
Category of Funding Organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
放射線医学総合研究所
Other administrative information
Date of disclosure of the study information
| 2013 | Year | 05 | Month | 31 | Day |
Related information
URL releasing protocol
http://www.nirs.go.jp/hospital/index.shtml
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2013 | Year | 05 | Month | 17 | Day |
Date of IRB
Anticipated trial start date
| 2013 | Year | 05 | Month | 17 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2013 | Year | 05 | Month | 31 | Day |
Last modified on
| 2015 | Year | 11 | Month | 30 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012703
